Jeremy V Camp
Overview
Explore the profile of Jeremy V Camp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
828
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nowotny N, Mandola M, Monne I, Bago Z, Nogarol C, Fusaro A, et al.
Viruses
. 2025 Jan;
17(1).
PMID: 39861911
The European subtype of tick-borne encephalitis virus (TBEV-Eur; species , family ) was the only tick-borne flavivirus present in central Europe known to cause neurologic disease in humans and several...
2.
Springer D, Camp J, Aberle S, Deutsch J, Lammel O, Weseslindtner L, et al.
J Med Virol
. 2024 Jul;
96(7):e29801.
PMID: 38988204
SARS-CoV-2 Omicron lineages continue to emerge and evolve into new sublineages, causing infection waves throughout 2022 and 2023, which has been attributed to immune escape. We examined neutralizing antibody responses...
3.
Buchta C, Aberle S, Gorzer I, Griesmacher A, Muller M, Neuwirth E, et al.
Wien Klin Wochenschr
. 2024 Apr;
136(15-16):429-438.
PMID: 38653873
Background: External quality assessment (EQA) schemes provide objective feedback to participating laboratories about the performance of their analytical systems and information about overall regional analytical performance. The EQAs are particularly...
4.
Camp J, Puchhammer-Stockl E, Aberle S, Buchta C
Front Mol Biosci
. 2024 Feb;
11:1327699.
PMID: 38375507
A notable feature of the 2019 coronavirus disease (COVID-19) pandemic was the widespread use of whole genome sequencing (WGS) to monitor severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Countries...
5.
Buchta C, Aberle S, Allerberger F, Benka B, Gorzer I, Griesmacher A, et al.
Lancet Microbe
. 2023 Nov;
4(12):e1015-e1023.
PMID: 37979591
Background: The aim of external quality assessment (EQA) schemes is to evaluate the analytical performance of laboratories and test systems in a near-to-real-life setting. This monitoring service provides feedback to...
6.
Springer D, Bauer M, Medits I, Camp J, Aberle S, Burtscher C, et al.
NPJ Vaccines
. 2023 Aug;
8(1):110.
PMID: 37542025
We report SARS-CoV-2 neutralizing antibody titers in sera of triple-vaccinated individuals who received a booster dose of an original monovalent or a bivalent BA.1- or BA.4/BA.5-adapted vaccine or had a...
7.
Weidinger P, Kolodziejek J, Loney T, Kannan D, Osman B, Khafaga T, et al.
Viruses
. 2023 Jun;
15(6).
PMID: 37376588
The main mode of transmission of Middle East respiratory syndrome-related coronavirus (MERS-CoV) between dromedaries is likely via the respiratory route. However, there must be other modes to explain how the...
8.
Jachs M, Panzer M, Hartl L, Schwarz M, Balcar L, Camp J, et al.
JHEP Rep
. 2023 Jun;
5(8):100751.
PMID: 37360907
Background & Aims: Bulevirtide (BLV) is a novel antiviral drug licensed for the treatment of chronic hepatitis D. Data on the safety and efficacy of stopping BLV therapy upon long-term...
9.
Redlberger-Fritz M, Springer D, Aberle S, Camp J, Aberle J
J Med Virol
. 2023 Jun;
95(6):e28830.
PMID: 37282809
In 2022, Austria experienced a severe respiratory syncytial virus (RSV) epidemic with an earlier-than-usual start (Weeks 35/2021-45/2022) and increased numbers of pediatric patients in emergency departments. This surge came 2...
10.
Buchta C, Zeichhardt H, Aberle S, Camp J, Gorzer I, Weseslindtner L, et al.
Lancet Microbe
. 2023 May;
4(7):e552-e562.
PMID: 37156257
During an epidemic, individual test results form the basis of epidemiological indicators such as case numbers or incidence. Therefore, the accuracy of measures derived from these indicators depends on the...